T. Rowe Price Associates’s PACS Group PACS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.63M Buy
38,251
+6,392
+20% +$230K ﹤0.01% 2109
2026
Q1
$1.02M Buy
31,859
+6,675
+27% +$245K ﹤0.01% 2142
2025
Q4
$967K Buy
25,184
+1,829
+8% +$40.1K ﹤0.01% 2097
2025
Q3
$321K Buy
23,355
+1,322
+6% +$15.5K ﹤0.01% 2568
2025
Q2
$285K Buy
22,033
+4,984
+29% +$51.8K ﹤0.01% 2553
2025
Q1
$192K Buy
17,049
+1,525
+10% +$20K ﹤0.01% 2661
2024
Q4
$204K Buy
15,524
+2,598
+20% +$66.7K ﹤0.01% 2673
2024
Q3
$517K Buy
+12,926
New +$470K ﹤0.01% 2229

Other funds holding PACS

T. Rowe Price Associates's PACS Position: Q2 2026 in Review

T. Rowe Price Associates increased its PACS Group (PACS) stake by 20% in Q2 2026, buying an estimated $230K and bringing the position to 38,251 shares worth $1.63M. The position accounts for ﹤0.01% of the portfolio, ranked #2109.

T. Rowe Price Associates first reported a position in PACS in Q3 2024 and has held it in 8 quarters since. 239 funds tracked by Wall St. Rank hold PACS as of Q2 2026.

  • T. Rowe Price Associates held 38,251 shares of PACS Group worth $1.63M as of Q2 2026.
  • T. Rowe Price Associates bought 6,392 PACS Group shares in Q2 2026, an estimated $230K.
  • PACS Group made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #2109 holding.
  • T. Rowe Price Associates first reported a position in PACS Group in Q3 2024 and has held it in 8 quarters since.
  • 239 funds tracked by Wall St. Rank held PACS Group as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.